Release Date: 14 July 2024
KIF18A, a member of the kinesin superfamily of motor proteins, plays a crucial role in mitotic spindle dynamics and chromosome alignment during cell division. Its normal function involves the precise regulation of microtu...
Release Date: 14 July 2024
Protein disulfide isomerase (PDI), a multifunctional enzyme primarily located in the endoplasmic reticulum, plays a crucial role in protein folding, assembly, and quality control. Its normal functions include catalyzing the formation, reduction, and ...
Release Date: 14 July 2024
PP2A, also known as protein phosphatase-2A, has shown great potential as a target for cancer treatment. By influencing important cellular signaling pathways that are crucial for tumor growth and survival, it offers a new ...
Release Date: 14 July 2024
Cancer is a complex and multifaceted disease that continues to pose significant challenges in the realm of drug development. One promising target that has gained attention in recent years is the secreted frizzled related ...
Release Date: 14 July 2024
Tumor necrosis factor (TNF)-like ligand 1a (TL1A) has emerged as a promising therapeutic target for autoimmune diseases and inflammatory conditions due to its critical role in regulating immune responses and inflammatory ...
Release Date: 14 July 2024
SLC15A4, also known as the peptide/histidine transporter solute carrier family 15 member A4, has emerged as a promising therapeutic target in the realm of autoimmune diseases and inflammatory conditions due to its crucial...
Release Date: 13 July 2024
Interleukin-21 (IL-21), a cytokine primarily produced by activated T cells and natural killer T cells, plays diverse roles in immune regulation, making it an attractive therapeutic target for various human diseases. Its m...
Release Date: 13 July 2024
Immune checkpoint-directed therapies have revolutionized cancer treatment by unleashing the body's immune system to combat tumors effectively. While agents targeting prominent checkpoints like PD-1/PD-L1 and CTLA-4 have s...
Release Date: 13 July 2024
Flap endonuclease 1 (FEN1) has emerged as a promising therapeutic target, particularly in the field of cancer research. This enzyme plays a crucial role in maintaining genomic stability by participating in various DNA rep...
Release Date: 13 July 2024
The DHX9 (DExH-Box Helicase 9) protein has emerged as a promising therapeutic target due to its multifaceted roles in various human diseases, with a primary focus on cancer. However, its implications extend beyond cancer,...
Release Date: 13 July 2024
The exploration of innovative therapeutic strategies for cancer has taken an exciting turn with the recent identification of DCAF5 as a potential target in the treatment of rhabdoid tumors. These tumors, which are aggress...
Release Date: 13 July 2024
The cyclic GMP-AMP synthase (cGAS) enzyme has emerged as a significant therapeutic target, with a major focus of research on autoimmune diseases and inflammatory conditions. The cGAS pathways plays a crucial role in the i...
Release Date: 13 July 2024
CEACAM1, or Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1, has recently emerged as a novel immune checkpoint with significant potential as a cancer therapeutic target. This transmembrane glycoprotein plays a m...
Release Date: 13 July 2024
In a landmark announcement in late April 2024, Pfizer unveiled a pivotal advancement in hemophilia B treatment with the US FDA’s approval of Beqvezandtrade; (fidanacogene elaparvovec-dzkt). This groundbreaking gene ...
Release Date: 13 July 2024
The B cell lymphoma 6 (BCL-6) protein serves as a key transcriptional repressor pivotal in governing gene expression throughout lymphocyte development and differentiation. Yet, its aberrant regulation has linked it to num...